Packaging

32


Packaging





Introduction


Pharmaceutical formulations must be suitably contained, protected and labelled from the time of manufacture until the patient uses them. Throughout this period, the container must maintain the quality, safety and stability of the medicine and protect the product against physical, climatic, chemical and biological hazards. The British Pharmacopoeia identifies the closure as part of the container.


To promote good patient compliance, the container must be user-friendly. Thus, containers should be easy to open and reclose, most notably for elderly or arthritic patients. Other factors must also be considered in the selection of the container used to package a pharmaceutical formulation, including the cost and the need for both child-resistant closures and tamper-evident seals.


Repackaging may be performed for dispensing purposes in the community and hospital pharmacies and in specialized production facilities (see Chs 30, 39). Bulk medicines are repackaged into smaller quantities in dispensing containers for distribution to hospital wards, clinics and general practitioners for direct supply to patients. This is mostly carried out with tablets and capsules that are transferred from bulk quantities into smaller amounts that are more suitable for patient use. In the UK, this process is performed in the hospital pharmacy where the MHRA allows the repackaging of small batches of up to 25 containers. Larger batches must be packed in licensed manufacturing premises. The facilities used for these repackaging operations are designed to maintain the quality of the medicine.


The composition of containers and closures used for the repackaging of bulk medicines must be carefully selected and must be of a quality as good as the original container. Both glass and plastic containers are used for repackaging but glass containers are often preferred due to the more inert qualities of glass.


Primary containers used for repackaging must not:



The container used in the repackaging process must protect the product from:



As the medicine has been transferred into a new container, the expiry date of the repackaged medicine must not exceed 12 months, unless the stability of the repackaged product justifies a longer shelf-life. The details of these repackaging processes must be recorded.


Each container of the repackaged batch is labelled with the:



There are some situations where the repackaging is limited, such as with glyceryl trinitrate tablets, owing to the potential loss of the volatile drug (see Ch. 39). Sterile products cannot easily be repackaged and require effective closure systems to minimize the risk of microbial contamination of the contents within the container. In addition, the pack itself must withstand sterilization procedures. Consequently, care must be applied to the selection of the container and its closure for the packaging of sterile products (see also Chs 40, 41, 44, 46).



Primary and secondary packaging


Primary packaging materials are in direct contact with the product. This also applies to the closure, which is also part of the primary pack. It is important that this container must not interact with the medicine. It must protect the medicine from damage and from extraneous chemical and microbial contamination. In addition, the primary packaging should support the use of the product by the patient. Secondary packages are additional packaging materials that improve the appearance of the product and include outer wrappers or labels that do not make direct contact with the product (Table 32.1). Secondary packages can also supply information about the product and its use. They should provide evidence of tampering with the medicine.



The following terms are used to describe containers:



Single-dose containers hold the medicine that is intended for single use. For example, a glass ampoule


Multidose containers hold a quantity of the material that will be used as two or more doses. For example, a multiple dose vial or a plastic tablet bottle


Well-closed containers protect the product from contamination with unwanted foreign materials and from loss of contents during use


Airtight containers are impermeable to solids, liquids and gases during normal storage and use. If the container is to be opened on more than one occasion it must remain airtight after reclosure


Sealed containers such as glass ampoules are closed by fusion of the container material


Tamper-evident containers are closed containers fitted with a device that irreversibly indicates if the container has been opened


Light-resistant containers protect the contents from the effect of radiation at a wavelength between 290 nm and 450 nm


Child-resistant containers, commonly referred to as CRCs, are designed to prevent children accessing the potentially hazardous product


Strip packs have at least one sealed pocket of material with each pocket containing a single dose of the product. The pack is made of two layers of film or laminate material. The nature and the level of protection that is required by the contained product will affect the composition of these layers


Blister packs are composed of a base layer, with cavities that contain the pharmaceutical product, and a lid. This lid is sealed to the base layer by heat, pressure or both. They are more rigid than strip packs and are not used for powders or semi-solids. Blister packs can be printed with day and week identifiers to produce calendar packs. These identifiers will support patient compliance


Tropicalized packs are blister packs with an additional aluminium membrane to provide greater protection against high humidity


Pressurized packs expel the product through a valve. The pressure for the expulsion of the product is provided by the positive pressure of the propellant that is often a compressed or liquefied gas (see Ch. 43)


Original packs are pharmaceutical packs that are commercially produced and intended for finite treatment periods. These packs are dispensed directly to the patient in their original form. Manufacturer’s information is contained on the pack but the pharmacist must attach a dispensing label.


An important consideration when selecting the packaging for any product is that its main objective is that the package must contribute to delivering a drug to a specific site of effective activity in the patient.


The selection of packaging for a pharmaceutical product is dependent on the following factors:




Packaging materials


Stay updated, free articles. Join our Telegram channel

Jun 24, 2016 | Posted by in PHARMACY | Comments Off on Packaging

Full access? Get Clinical Tree

Get Clinical Tree app for offline access